Akebia Therapeutics (AKBA) Goodwill (2018 - 2025)
Historic Goodwill for Akebia Therapeutics (AKBA) over the last 8 years, with Q3 2025 value amounting to $59.0 million.
- Akebia Therapeutics' Goodwill changed 0.0% to $59.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $59.0 million for FY2024, which is 0.0% changed from last year.
- Per Akebia Therapeutics' latest filing, its Goodwill stood at $59.0 million for Q3 2025, which was down 0.0% from $59.0 million recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Goodwill ranged from a high of $59.0 million in Q4 2021 and a low of $55.1 million during Q1 2021
- In the last 5 years, Akebia Therapeutics' Goodwill had a median value of $59.0 million in 2021 and averaged $58.4 million.
- Examining YoY changes over the last 5 years, Akebia Therapeutics' Goodwill showed a top increase of 715.79% in 2021 and a maximum decrease of 0.0% in 2021.
- Akebia Therapeutics' Goodwill (Quarter) stood at $59.0 million in 2021, then changed by 0.0% to $59.0 million in 2022, then changed by 0.0% to $59.0 million in 2023, then changed by 0.0% to $59.0 million in 2024, then changed by 0.0% to $59.0 million in 2025.
- Its Goodwill stands at $59.0 million for Q3 2025, versus $59.0 million for Q2 2025 and $59.0 million for Q1 2025.